LYKALABSNSELyka Labs Limited· PharmaceuticalsMediumNeutral
Announced Thu, 9 Apr · 10:50 IST

Significant movement in price has been observed in Lyka Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Lyka Labs Limited has submitted their response.

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.9%1-day move
₹58.53
prior close
₹59.75
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.4-0.4-0.8-0.9-1.0-2.8-1.4+2.4+0.9+2.3+9.3+19.7+19.6
Up moveDown movePending
AI summary

NSE wrote to Lyka Labs Limited on April 8, 2026 seeking clarification on significant price movement observed in the company's stock. In response dated April 9, 2026, the company stated that there are no material information or material events that required disclosure under SEBI regulations and which in their opinion could explain the price movement. The company confirmed it has been regularly disseminating relevant information as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The clarification was signed by Shailendra Kumar Agrawal, Company Secretary and Compliance Officer.

Likely market impact

The stock may experience continued volatility as no undisclosed material development was identified behind the price movement. This 'no news' clarification provides some reassurance that there is no hidden negative information, though investors should remain cautious given the unexplained activity.